Syndax Pharmaceuticals Inc (SNDX)
Stock-Based Compensation
$14.01M
Quarterly · Period ending: · USD
SNDX Stock-Based Compensation
Latest reported$14.01Mperiod ending
Latest reported$14.01Mperiod ending
SNDX Quarterly Stock-Based Comp ($45.00 → $14.01M)
Quarterly stock-based compensation
High-resolution chart · PNG
SNDX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 14,013,000 | |
| 12,054,000 | |
| 11,254,000 | |
| 12,082,000 | |
| 13,787,000 | |
| 10,380,000 | |
| 12,297,000 | |
| 11,934,000 | |
| 9,896,000 | |
| 8,899,000 | |
| 8,327,000 | |
| 8,321,000 | |
| 8,065,000 | |
| 6,238,000 | |
| 4,241,000 | |
| 4,362,000 | |
| 3,938,000 | |
| 3,478,000 | |
| 3,929,000 | |
| 3,381,000 | |
| 3,240,000 | |
| 2,767,000 | |
| 2,035,000 | |
| 3,063,000 | |
| 2,130,000 | |
| 1,829,000 | |
| 1,525,000 | |
| 1,550,000 | |
| 1,338,000 | |
| 1,592,000 | |
| 1,472,000 | |
| 1,737,000 | |
| 1,571,000 | |
| 1,421,000 | |
| 1,280,000 | |
| 1,345,000 | |
| 1,448,000 | |
| 1,377,000 | |
| 947,000 | |
| 792,000 | |
| 779,000 | |
| 2,190,000 | |
| 1,170,000 | |
| 1,288,000 | |
| 1,100,000 | |
| 324,000 | |
| 410,000 | |
| 884,000 | |
| 364,000 | |
| 599,000 | |
| 412,000 | |
| 178,000 | |
| 810,000 | |
| 15,000 | |
| 45 |